JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NOA
5526
North American Construction
NOA
$326M
| $131K | ﹤0.01% |
+9,105
| New | +$130K |
2025 Q4
0 quarters
|
|
|
DOG
5527
ProShares Short Dow30
DOG
$111M
| $131K | ﹤0.01% |
5,567
+5,381
| +2,893% | +$129K |
2024 Q4
4 quarters
|
|
5528
Delcath Systems
DCTH
$535M
| $131K | ﹤0.01% |
12,927
+426
| +3% | +$4.24K |
2025 Q1
3 quarters
|
|
|
CTEV
5529
Claritev Corp
CTEV
$361M
| $130K | ﹤0.01% |
3,049
-20,415
| -87% | -$1.04M |
2020 Q3
21 quarters
|
|
5530
FT Vest US Equity Moderate Buffer ETF July
GJUL
$414M
| $130K | ﹤0.01% |
+3,153
| New | +$129K |
2025 Q3
1 quarter
|
|
|
VHCPU
5531
Vine Hill Capital Investment Corp II Units
VHCPU
$179M
| $130K | ﹤0.01% |
+13,000
| New | +$130K |
2025 Q4
0 quarters
|
|
5532
Reaves Utility Income Fund
UTG
$3.18B
| $130K | ﹤0.01% |
3,556
-13
| -0.4% | -$494 |
2023 Q4
8 quarters
|
|
5533
First United
FUNC
$283M
| $130K | ﹤0.01% |
3,473
-1,735
| -33% | -$64.5K |
2025 Q2
2 quarters
|
|
|
BCYC
5534
Bicycle Therapeutics
BCYC
$249M
| $130K | ﹤0.01% |
18,355
+10,228
| +126% | +$75.4K |
2021 Q1
19 quarters
|
|
5535
KRONOS Worldwide
KRO
$878M
| $130K | ﹤0.01% |
29,382
+9,114
| +45% | +$44.2K |
2017 Q4
32 quarters
|
|
5536
PUT
Kinross Gold
KGC
$28.5B
| $130K | ﹤0.01% |
4,600
| – | – |
2025 Q3
1 quarter
|
|
5537
Fidelity Low Duration Bond Factor ETF
FLDR
$2.32B
| $129K | ﹤0.01% |
2,568
+806
| +46% | +$40.6K |
2023 Q3
9 quarters
|
|
|
EMPG
5538
DELISTED
Empro Group
EMPG
| $129K | ﹤0.01% |
+7,426
| New | +$127K |
2025 Q4
0 quarters
|
|
5539
Immunocore
IMCR
$1.57B
| $128K | ﹤0.01% |
3,699
+494
| +15% | +$17.4K |
2022 Q2
14 quarters
|
|
|
XHYF
5540
DELISTED
BondBloxx USD High Yield Bond Financial & REIT Sector ETF
XHYF
| $128K | ﹤0.01% |
3,375
-2,205
| -40% | -$83.6K |
2024 Q2
6 quarters
|
|
5541
Byrna Technologies
BYRN
$81.4M
| $127K | ﹤0.01% |
7,590
-257
| -3% | -$5K |
2024 Q2
6 quarters
|
|
5542
First Trust Indxx NextG ETF
NXTG
$564M
| $126K | ﹤0.01% |
1,170
| – | – |
2021 Q3
17 quarters
|
|
5543
Aura Biosciences
AURA
$626M
| $126K | ﹤0.01% |
23,119
-1,438
| -6% | -$8.54K |
2021 Q4
16 quarters
|
|
5544
CB Financial Services
CBFV
$189M
| $126K | ﹤0.01% |
3,610
-599
| -14% | -$20.3K |
2025 Q1
3 quarters
|
|
5545
Vanguard California Tax-Exempt Bond ETF
VTEC
$3.2B
| $126K | ﹤0.01% |
1,254
| – | – |
2025 Q1
3 quarters
|
|
5546
MasterCraft Boat Holdings
MCFT
$483M
| $126K | ﹤0.01% |
6,648
-106,282
| -94% | -$2.1M |
2017 Q4
32 quarters
|
|
5547
Puma Biotechnology
PBYI
$508M
| $126K | ﹤0.01% |
21,108
+3,823
| +22% | +$20.3K |
2013 Q2
50 quarters
|
|
5548
Spire Global
SPIR
$429M
| $125K | ﹤0.01% |
16,667
-17,210
| -51% | -$168K |
2021 Q3
17 quarters
|
|
5549
Lifecore Biomedical
LFCR
$248M
| $125K | ﹤0.01% |
15,221
+2,917
| +24% | +$21.6K |
2017 Q4
32 quarters
|
|
5550
Alvotech
ALVO
$2.01B
| $124K | ﹤0.01% |
24,249
-206
| -0.8% | -$1.3K |
2024 Q1
7 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.